TNF Pharmaceuticals, Inc. (LON:0A8D)
London · Delayed Price · Currency is GBP · Price in USD 0.0972
+0.0043 (4.57%)
At close: Aug 20, 2025
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 2 employees as of December 31, 2024. The number of employees decreased by 4 or -66.67% compared to the previous year.
Employees
2
Change (1Y)
-4
Growth (1Y)
-66.67%
Revenue / Employee
n/a
Profits / Employee
-1.28M GBP
Market Cap
8.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | -4 | -66.67% |
| Dec 31, 2023 | 6 | -3 | -33.33% |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| HSBC Holdings | 211,304 |
| Shell | 96,000 |
| Unilever | 115,964 |
| British American Tobacco p.l.c. | 48,989 |
| Rolls-Royce Holdings | 42,400 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
TNF Pharmaceuticals News
- 23 days ago - OpenAI spearheads one of Europes biggest data centers with 100,000 Nvidia chips - CNBC
- 23 days ago - Nscale, Aker, and OpenAI to launch Stargate Norway with 230 MW data center - Seeking Alpha
- 4 months ago - SLB Capturi aims to clean up Europe’s polluting industry - The Armchair Trader
- 6 months ago - Aker outlines 5% dividend growth for Aker BP in 2025 amid strong cash flow and portfolio streamlining - Seeking Alpha
- 4 years ago - Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger - Business Wire
- 4 years ago - Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial - Business Wire
- 4 years ago - Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board - Business Wire
- 4 years ago - Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals - Business Wire